Highlights from the 2023 ESMO CongressTake an interactive tour01 Introduction02 The place of antibody–drug conjugates in the evolving treatment landscape of solid tumors03 Aiming for a change in clinical practice in NSCLC04 Updates in precision medicine and the continuing hunt for biomarkers05 Medical innovation, artificial intelligence, and the potential for a new era of oncology care06 Until next time07 Our contributors
